Actions are Part of Enhanced Oversight; FDA Does Not Advise Discarding or Avoiding Purchase of Any Particular Infant Formula SILVER SPRING, Md., Aug. 30, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.